miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury

Background: Mitochondria are dynamic organelles whose structure are maintained by continuous fusion and fission. During acute kidney injury (AKI) progression, mitochondrial fission in renal tubular cells was elevated, characterized by mitochondrial fragmentation. It is tightly associated with mitoch...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yue Zhao, Yue Lang, Mingchao Zhang, Shaoshan Liang, Xiaodong Zhu, Zhihong Liu
Formato: article
Lenguaje:EN
Publicado: Karger Publishers 2021
Materias:
Acceso en línea:https://doaj.org/article/c8956efae8bd47b38fa60b6b5e14180c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c8956efae8bd47b38fa60b6b5e14180c
record_format dspace
spelling oai:doaj.org-article:c8956efae8bd47b38fa60b6b5e14180c2021-12-02T12:40:23ZmiR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury2296-93812296-935710.1159/000520140https://doaj.org/article/c8956efae8bd47b38fa60b6b5e14180c2021-11-01T00:00:00Zhttps://www.karger.com/Article/FullText/520140https://doaj.org/toc/2296-9381https://doaj.org/toc/2296-9357Background: Mitochondria are dynamic organelles whose structure are maintained by continuous fusion and fission. During acute kidney injury (AKI) progression, mitochondrial fission in renal tubular cells was elevated, characterized by mitochondrial fragmentation. It is tightly associated with mitochondrial dysfunction, which has been proven as a critical mechanism responsible for AKI. However, the initiating factor for the disruption of mitochondrial dynamics in AKI was not well understood. Objectives: To explore the molecular mechanisms of mitochondrial disorders and kidney damage. Methods: We established cisplatin-induced AKI model in C57BL/6 mice and proximal tubular cells, and detected the expression of miR-125b by qPCR. Then we delivered miR-125b antagomir after cisplatin treatment in mice via hydrodynamic-based gene transfer technique. Subsequently, we performed luciferase reporter and immunoblotting ­assays to prove miR-125b could directly modulate mitofusin1 (MFN1) expression. We also tested the role of miR-125b in mitochondrial and renal injury through immunofluorescent staining, qPCR, and immunoblotting assays. Results: miR-125b levels were induced in cisplatin-challenged mice and cultured tubular cells. Anti-miR-125b could effectively alleviate cisplatin-induced mitochondrial fragmentation and kidney injury both in vitro and in vivo. Furthermore, miR-125b could directly regulate MFN1, which is a key regulator of mitochondrial fusion. Our study indicated that miR-125b is upregulated during cisplatin-induced AKI. Inhibition of miR-125b may suppress mitochondrial and renal damage through upregulating MFN1. This study suggests that miR-125b could be a potential therapeutic target in AKI.Yue ZhaoYue LangMingchao ZhangShaoshan LiangXiaodong ZhuZhihong LiuKarger Publishersarticlemir-125bacute kidney injurycisplatinmitochondrial fragmentationInternal medicineRC31-1245ENKidney Diseases, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic mir-125b
acute kidney injury
cisplatin
mitochondrial fragmentation
Internal medicine
RC31-1245
spellingShingle mir-125b
acute kidney injury
cisplatin
mitochondrial fragmentation
Internal medicine
RC31-1245
Yue Zhao
Yue Lang
Mingchao Zhang
Shaoshan Liang
Xiaodong Zhu
Zhihong Liu
miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury
description Background: Mitochondria are dynamic organelles whose structure are maintained by continuous fusion and fission. During acute kidney injury (AKI) progression, mitochondrial fission in renal tubular cells was elevated, characterized by mitochondrial fragmentation. It is tightly associated with mitochondrial dysfunction, which has been proven as a critical mechanism responsible for AKI. However, the initiating factor for the disruption of mitochondrial dynamics in AKI was not well understood. Objectives: To explore the molecular mechanisms of mitochondrial disorders and kidney damage. Methods: We established cisplatin-induced AKI model in C57BL/6 mice and proximal tubular cells, and detected the expression of miR-125b by qPCR. Then we delivered miR-125b antagomir after cisplatin treatment in mice via hydrodynamic-based gene transfer technique. Subsequently, we performed luciferase reporter and immunoblotting ­assays to prove miR-125b could directly modulate mitofusin1 (MFN1) expression. We also tested the role of miR-125b in mitochondrial and renal injury through immunofluorescent staining, qPCR, and immunoblotting assays. Results: miR-125b levels were induced in cisplatin-challenged mice and cultured tubular cells. Anti-miR-125b could effectively alleviate cisplatin-induced mitochondrial fragmentation and kidney injury both in vitro and in vivo. Furthermore, miR-125b could directly regulate MFN1, which is a key regulator of mitochondrial fusion. Our study indicated that miR-125b is upregulated during cisplatin-induced AKI. Inhibition of miR-125b may suppress mitochondrial and renal damage through upregulating MFN1. This study suggests that miR-125b could be a potential therapeutic target in AKI.
format article
author Yue Zhao
Yue Lang
Mingchao Zhang
Shaoshan Liang
Xiaodong Zhu
Zhihong Liu
author_facet Yue Zhao
Yue Lang
Mingchao Zhang
Shaoshan Liang
Xiaodong Zhu
Zhihong Liu
author_sort Yue Zhao
title miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury
title_short miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury
title_full miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury
title_fullStr miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury
title_full_unstemmed miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury
title_sort mir-125b disrupts mitochondrial dynamics via targeting mitofusin 1 in cisplatin-induced acute kidney injury
publisher Karger Publishers
publishDate 2021
url https://doaj.org/article/c8956efae8bd47b38fa60b6b5e14180c
work_keys_str_mv AT yuezhao mir125bdisruptsmitochondrialdynamicsviatargetingmitofusin1incisplatininducedacutekidneyinjury
AT yuelang mir125bdisruptsmitochondrialdynamicsviatargetingmitofusin1incisplatininducedacutekidneyinjury
AT mingchaozhang mir125bdisruptsmitochondrialdynamicsviatargetingmitofusin1incisplatininducedacutekidneyinjury
AT shaoshanliang mir125bdisruptsmitochondrialdynamicsviatargetingmitofusin1incisplatininducedacutekidneyinjury
AT xiaodongzhu mir125bdisruptsmitochondrialdynamicsviatargetingmitofusin1incisplatininducedacutekidneyinjury
AT zhihongliu mir125bdisruptsmitochondrialdynamicsviatargetingmitofusin1incisplatininducedacutekidneyinjury
_version_ 1718393766657654784